Mr Tomasz Siembida used to work for Bioton S.A. as an advisor from 2008, where was a lead negotiator on various joint venture projects, in particular those relating to the development of biotechnology projects (Actavis, GSK), as well as advising on corporate issues.
He is the CEO of UniApek S.A. He held several positions, among the others, at the legal firm Czabański & Gałuszyński as the Partner (June 2017 – 2019) and at Weil Gotshal Manges as the Counsel (2011-2017).
He has obtained the master’s degree at sociology and law and the University of Szczecin. He is the the member of the Polish National Bar of Legal Advisors.
He is also recognized as a ‘notable practitioner’ by IFLR 1000.